Atom Bioworks is a developer of a pattern-recognition enabled sensing and therapeutics platform designed to help in medical.
Atom Bioworks has raised $999K in total funding. The most recent round was Grant. The last funding was announced in July 2022.
Atom Bioworks's investors include Y Combinator, National Science Foundation, TechU Ventures, National Institutes of Health, BioTools Innovator.
Atom Bioworks is headquartered in Cary, United States.
Atom Bioworks is a developer of a pattern-recognition enabled sensing and therapeutics platform designed to help in medical.
Atom Bioworks is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Atom Bioworks — Funding & Investors." VCBacked, July 20, 2022, https://www.vcbacked.co/company/atom-bioworks. Accessed July 20, 2026.
VCBacked. (2022). Atom Bioworks — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/atom-bioworks
{{cite web |title=Atom Bioworks — Funding & Investors |url=https://www.vcbacked.co/company/atom-bioworks |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated